Phthalate Chemicals Tied to Costly Preterm Births in the United States
FRIDAY, Feb. 9, 2024 -- Hormone disruptor phthalate chemicals were associated with nearly 56,600 preterm births in the United States in 2018, according to a study published online Feb. 6 in The Lancet Planetary Health. Leonardo Trasande, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2024 Category: Pharmaceuticals Source Type: news

EPA data finds more than 70MILLION Americans are living in homes with tap water that is laced with hormone-warping 'forever chemicals'... is YOUR area affected?
The new results showed that PFAS was resent in 33 percent of systems tested by the EPA in its latest report - with contamination most common in densely populated coastal cities. (Source: the Mail online | Health)
Source: the Mail online | Health - February 9, 2024 Category: Consumer Health News Source Type: news

EPA data finds more than 70MILLION Americans are living in home with tap water that is laced with hormone-warping 'forever chemicals'... is YOUR area affected?
The new results showed that PFAS was resent in 33 percent of systems tested by the EPA in its latest report - with contamination most common in densely populated coastal cities. (Source: the Mail online | Health)
Source: the Mail online | Health - February 8, 2024 Category: Consumer Health News Source Type: news

Why are we still waiting for a male contraceptive pill? | podcast
Despite research into a male contraceptive pill starting around the same time as its female counterpart, no product has ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample speaks to bioethicist Prof Lisa Campo-Engelstein of the University of Texas and Prof Chris Barratt from the University of Dundee about why male contraceptives have been so difficult to develop, and what kind of options are in the pipelineContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 8, 2024 Category: Science Authors: Presented by Ian Sample, produced by Madeleine Finlay and Eli Block sound design by Tony Onuchukwu, the executive producer is Ellie Bury Tags: Science Medical research Contraception and family planning Health Men's health Women's health Society Reproduction Biology Source Type: news

‘No hormones, ever,’ Shake Shack says about its chicken. Activist shareholders say that’s true for every other chicken sold in the U.S., too
“No hormones, ever” is what Shake Shack said about the crispy fried chicken in its sandwiches. A shareholder group says that’s a paltry claim, because literally no restaurant chain in the country uses hormones in its chicken. The company’s corporate communications and marketing are heavy on the…#shakeshack #randygarutti #accountabilityboard #mcdonalds #wendyscompany #joshbalk #shakeshackcant #ashakeshack #activist #carlicahn (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2024 Category: Consumer Health News Source Type: news

Women exposed to 'everyday' plastics are up to 50 percent more likely to have a preterm birth, study suggests
Researchers at New York University estimated 10 percent of preterm births in 2018 were tied to chemicals known to disrupt the body's hormones. (Source: the Mail online | Health)
Source: the Mail online | Health - February 6, 2024 Category: Consumer Health News Source Type: news

Women with polycystic ovary syndrome are eight times more likely to try to kill themselves, according to study of 18,000 patients
Women with a common hormone disorder had a greater than eight-fold-increased risk for attempting suicide than those without the condition, according to a new study from Taiwan. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2024 Category: Consumer Health News Source Type: news

An Experimental Weight-Loss Drug Shows Lasting Results in Early Study
An experimental weight-loss shot from Amgen Inc.—taken less frequently than wildly popular treatments from Eli Lilly & Co. and Novo Nordisk A/S—appears to keep weight off even after patients stop taking it. Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism. And some people kept the weight off for up to 150 days after stopping the drug, findings show. [time-brightcove not-tgx=”true”] “That is really a remarkable and...
Source: TIME: Health - February 5, 2024 Category: Consumer Health News Authors: Madison Muller/Bloomberg Tags: Uncategorized bloomberg wire healthscienceclimate Source Type: news

UN trans health panel accused of CRONYISM: 80% of WHO's 'experts' flagged for conflicts of interest - eyeing profits from hormones and sex-change ops they're pushing as global standards
'A lot of organizations struggle when managing intellectual conflicts of interest, but a financial conflict of interest is kindergarten level,' famed whistleblower Jamie Reed told DailyMail.com. (Source: the Mail online | Health)
Source: the Mail online | Health - February 3, 2024 Category: Consumer Health News Source Type: news

' It's Time' to Empower Care for Patients With Obesity'It's Time' to Empower Care for Patients With Obesity
Combining nutrient-stimulated hormonal therapies and metabolic bariatric surgery with behavior modification leads to more weight loss, but are clinicians informing patients?Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 2, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news

Experts say all anti-aging routines are pointless without one secret ingredient - and it costs nothing
All the creams in the world won't help your skin if you're lacking hormones like melatonin, which combat UV damage and free radicals that age the skin. Thankfully, there's a quick fix for that. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2024 Category: Consumer Health News Source Type: news

Transgender woman said sex hormones she took to transition made her SHRINK
Shaye Scott, 39, a transgender woman from Utah, was 6 foot 5 inches before she transitioned, and shrunk to 6 foot 2 inches while on female hormones. Her wife measured her new height. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2024 Category: Consumer Health News Source Type: news

I was injected with growth hormones harvested from CORPSES as a child - now I'm at risk of Alzheimer's and another terrifying illness that can kill within a year
For the last 30 years, Dave Richardson has faced the terrifying prospect of being struck down with an incurable brain disease so deadly that it usually kills patients within a year. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2024 Category: Consumer Health News Source Type: news

Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI
Men with metastatic castration-resistant prostate cancer had a slight but significant improvement in progression-free survival with a TKI plus immunotherapy vs hormonal therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news